✦ LIBER ✦

Multicenter phase II study of weekly paclitaxel plus S-1 combination chemotherapy in patients with advanced gastric cancer

✍ Scribed by Yuji Ueda; Hisakazu Yamagishi; Daisuke Ichikawa; Kazuma Okamoto; Eigo Otsuji; Jun Morii; Kinya Koizumi; Naoki Kakihara; Masataka Shimotsuma; Tetsuro Yamashita; Fumihiro Taniguchi; Hideki Aragane; Hiroshi Nishi; Yoshiki Itokawa; Satoshi Morita; Junichi Sakamoto

Publisher: Springer
Year: 2010
Tongue: English
Weight: 210 KB
Volume: 13
Category: Article
ISSN: 1436-3291
DOI: 10.1007/s10120-010-0548-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Multicenter phase II study of weekly pac

Multicenter phase II study of weekly paclitaxel plus cisplatin combination chemotherapy in patients with advanced gastric cancer

✍ Jong Gwang Kim; Sang Kyun Sohn; Hong Suk Song; Ki-Young Kwon; Young Rok Do; Kyun 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 306 KB

Multicenter phase II trial of S-1, pacli

Multicenter phase II trial of S-1, paclitaxel and cisplatin triplet combination chemotherapy in patients with advanced gastric cancer

✍ Jin Young Kim; Young Rok Do; Keon Uk Park; Jong Gwang Kim; Yee Soo Chae; Min Kyo 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 267 KB

A phase I combination chemotherapy study

A phase I combination chemotherapy study of biweekly paclitaxel and S-1 administration in patients with advanced gastric cancer

✍ Shuichi Hokita; Takashi Aikou; Futoshi Miyazono; Sumiya Ishigami; Kuniaki Aridom 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 201 KB

Multicenter, phase II study of gemcitabi

Multicenter, phase II study of gemcitabine and S-1 combination chemotherapy in patients with advanced biliary tract cancer

✍ Takashi Sasaki; Hiroyuki Isayama; Yousuke Nakai; Yukiko Ito; Hirofumi Kogure; Os 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 169 KB

A multicenter phase II study of biweekly

A multicenter phase II study of biweekly paclitaxel and S-1 combination chemotherapy for unresectable or recurrent gastric cancer

✍ Akihiro Nakajo; Shuichi Hokita; Sumiya Ishigami; Futoshi Miyazono; Tadaaki Etoh; 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 299 KB

Multicenter Phase II study of estramusti

Multicenter Phase II study of estramustine phosphate plus weekly paclitaxel in patients with androgen-independent prostate carcinoma

✍ David J. Vaughn; Archie W. Brown Jr.; W. Graydon Harker; Sang Huh; Lance Miller; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB 👁 2 views

## Abstract ## BACKGROUND The current study determined the efficacy and toxicity of weekly paclitaxel in combination with estramustine phosphate (EMP) in patients with androgen‐independent prostate carcinoma (AIPC). ## METHODS Patients with progressive AIPC received 90 mg/m^2^ paclitaxel by 1‐ho